The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global vaccine vials market size reached US$ 576.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,056.0 Million by 2028, exhibiting a growth rate (CAGR) of 10.30% during 2023-2028.
Vaccine vials are cylindrical-shaped, small-sized storage units manufactured from glass material to store liquid medicines. They are highly resistant to enzymes and moderately resilient to temperature changes. They are also chemically inert and consequently do not react with the material stored inside. At present, they are commonly available in single and multi-doze variants. The single-doze vaccine vials are used once, while the multi-doze vaccine vials can be utilized more than once.
The increasing number of individuals with chronic medical conditions and viral infections currently represents one of the major factors driving the demand for vaccine vials around the world. The rising aging population, which is more prone to severe medical ailments, and significant improvements in the healthcare infrastructure and medical services are also strengthening the growth of the market. Moreover, the growing incidences of airborne diseases on account of the increasing air pollution are influencing the market positively. In addition, governments of numerous countries are undertaking initiatives to monitor the distribution, supply, and administration of vaccine vials, which is contributing to the growth of the market. Apart from this, the growing budget of pharmaceutical companies for research and development (R&D) projects to improve product effectiveness is creating a positive outlook for the market. Furthermore, key players are incorporating vaccine vial monitors (VVMs) that help indicate exposure of the vaccine to cumulative heat via a change in color. These monitors also assist health workers in knowing whether the vaccine has exceeded a pre-set limit beyond which the vaccine should not be used. This, in turn, is anticipated to provide a favorable market outlook in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaccine vials market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, material, capacity and application.
Breakup by Type:
Breakup by Material:
Breakup by Capacity:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Anhui Huaxin Medicinal Glass Products Co. Ltd., Berlin Packaging LLC, Corning Incorporated, DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co. Ltd., JOTOP Glass, Richland Glass Company, Schott AG, Shandong Pharmaceutical Glass Co. Ltd. and Stevanato Group. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis||2022|
|Segment Coverage||Type, Material, Capacity, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Anhui Huaxin Medicinal Glass Products Co. Ltd., Berlin Packaging LLC, Corning Incorporated, DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co. Ltd., JOTOP Glass, Richland Glass Company, Schott AG, Shandong Pharmaceutical Glass Co. Ltd. and Stevanato Group.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at